A synthetic peptide analogue investigated for its interaction with growth hormone–releasing hormone pathways. It is commonly studied in research involving peptide-receptor interactions, endocrine signaling, growth hormone pathways, and structure-activity relationships.
Not for human consumption
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids with a molecular weight of approximately 5,135.9 Da. Structural modifications at the N-terminus improve enzymatic stability while preserving receptor-binding characteristics, making it well suited for laboratory research applications.
Tesamorelin has been extensively characterized in the scientific literature for its selective interaction with the growth hormone-releasing hormone receptor (GHRHR) and serves as a widely recognized research tool for investigating endocrine signaling, peptide-receptor pharmacology, pituitary physiology, and structure-activity relationships.
You must be at least 21 years old to access The Research Peptides.
All products are sold strictly for in-vitro laboratory research use only.